A translational rheostat for RFLAT-1 regulates RANTES expression in T lymphocytes

被引:55
作者
Nikolcheva, T
Pyronnet, S
Chou, SY
Sonenberg, N
Song, A
Clayberger, C
Krensky, AM
机构
[1] Stanford Univ, Sch Med, Dept Pediat, Div Immunol & Transplantat Biol, Stanford, CA 94305 USA
[2] McGill Univ, Dept Biochem, Montreal, PQ, Canada
[3] Stanford Univ, Sch Med, Dept Cardiothorac Surg, Stanford, CA 94305 USA
关键词
D O I
10.1172/JCI200215336
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Activation of T lymphocytes by specific antigen triggers a 3- to 7-day maturation process. Terminal differentiation begins late after T cell activation and involves expression of effector genes, including the chemokine RANTES and its major transcriptional regulator, RANTES factor of late-activated T lymphocytes-1 (RFLAT-1). In this article we demonstrate that RFLAT-1 expression is translationally regulated through its 5'-UTR and in a cell type-specific manner. Overexpression of the translation initiation factor eIF4E increases RFLAT-1 protein, while inhibition of Mnk1, which phosphorylates eIF4E, reduces RFLAT-1 production, indicating cap-dependent translational regulation. These events are regulated by ER-K-1/2 and p38 MAP kinases and allow T cells to rapidly adjust RANTES expression in response to changes in the cellular environment, such as stress and/or growth factors. These findings provide a molecular mechanism for a rheostat effect of increasing or decreasing RANTES expression at sites of inflammation. Memory T cells, already poised to make RANTES, are finely regulated by translational control of the major transcription factor regulating RANTES expression. This is the first example of such a mechanism regulating a chemokine, but it seems likely that this will prove to be a general way for cells to rapidly respond to stress, cytokines, and other proinflammatory factors in their local environment.
引用
收藏
页码:119 / 126
页数:8
相关论文
共 49 条
[1]  
ALAM R, 1993, J IMMUNOL, V150, P3442
[2]   CC CKRS: A RANTES, MIP-1 alpha, MIP-1 beta receptor as a fusion cofactor for macrophage-tropic HIV-1 [J].
Alkhatib, G ;
Combadiere, C ;
Broder, CC ;
Feng, Y ;
Kennedy, PE ;
Murphy, PM ;
Berger, EA .
SCIENCE, 1996, 272 (5270) :1955-1958
[3]   ACTIVATION OF DUAL T-CELL SIGNALING PATHWAYS BY THE CHEMOKINE RANTES [J].
BACON, KB ;
PREMACK, BA ;
GARDNER, P ;
SCHALL, TJ .
SCIENCE, 1995, 269 (5231) :1727-1730
[4]   Human interferon-γ mRNA autoregulates its translation through a pseudoknot that activates the interferon-inducible protein kinase PKR [J].
Ben-Asouli, Y ;
Banai, Y ;
Pel-Or, Y ;
Shir, A ;
Kaempfer, R .
CELL, 2002, 108 (02) :221-232
[5]   REGULATION OF EUKARYOTIC TRANSLATION INITIATION-FACTOR EXPRESSION DURING T-CELL ACTIVATION [J].
BOAL, TR ;
CHIORINI, JA ;
COHEN, RB ;
MIYAMOTO, S ;
FREDERICKSON, RM ;
SONENBERG, N ;
SAFER, B .
BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1176 (03) :257-264
[6]   A human class II MHC-derived peptide antagonizes phosphatidylinositol 3-kinase to block IL-2 signaling [J].
Boytim, ML ;
Lilly, P ;
Drouvalakis, K ;
Lyu, SC ;
Jung, R ;
Krensky, AM ;
Clayberger, C .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (10) :1447-1453
[7]  
BU X, 1993, J BIOL CHEM, V268, P4975
[8]   The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates [J].
Choe, H ;
Farzan, M ;
Sun, Y ;
Sullivan, N ;
Rollins, B ;
Ponath, PD ;
Wu, LJ ;
Mackay, CR ;
LaRosa, G ;
Newman, W ;
Gerard, N ;
Gerard, C ;
Sodroski, J .
CELL, 1996, 85 (07) :1135-1148
[9]   Translational control: the cancer connection [J].
Clemens, MJ ;
Bommer, UA .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 1999, 31 (01) :1-23
[10]   IDENTIFICATION OF RANTES, MIP-1-ALPHA, AND MIP-1-BETA AS THE MAJOR HIV-SUPPRESSIVE FACTORS PRODUCED BY CD8(+) T-CELLS [J].
COCCHI, F ;
DEVICO, AL ;
GARZINODEMO, A ;
ARYA, SK ;
GALLO, RC ;
LUSSO, P .
SCIENCE, 1995, 270 (5243) :1811-1815